Your browser is no longer supported. Please, upgrade your browser.
Adial Pharmaceuticals, Inc.
Index- P/E- EPS (ttm)-0.82 Insider Own6.50% Shs Outstand13.65M Perf Week-7.09%
Market Cap39.44M Forward P/E- EPS next Y-0.64 Insider Trans0.00% Shs Float11.64M Perf Month17.52%
Income-9.50M PEG- EPS next Q-0.25 Inst Own10.20% Short Float4.04% Perf Quarter48.65%
Sales- P/S- EPS this Y64.30% Inst Trans4.35% Short Ratio0.69 Perf Half Y93.66%
Book/sh0.52 P/B5.29 EPS next Y28.10% ROA-121.30% Target Price- Perf Year71.88%
Cash/sh0.52 P/C5.33 EPS next 5Y- ROE-132.80% 52W Range1.00 - 4.00 Perf YTD61.76%
Dividend- P/FCF- EPS past 5Y- ROI- 52W High-36.00% Beta-
Dividend %- Quick Ratio7.50 Sales past 5Y- Gross Margin- 52W Low156.00% ATR0.32
Employees3 Current Ratio7.50 Sales Q/Q- Oper. Margin- RSI (14)47.28 Volatility16.23% 12.41%
OptionableNo Debt/Eq0.00 EPS Q/Q-46.10% Profit Margin- Rel Volume1.65 Prev Close2.75
ShortableYes LT Debt/Eq0.00 Earnings- Payout- Avg Volume681.69K Price2.56
Recom2.00 SMA20-7.03% SMA5013.02% SMA20042.77% Volume766,346 Change-6.91%
Oct-30-18Initiated Maxim Group Buy $5
Oct-11-18Initiated Dawson James Buy
Feb-26-21 11:20AM  
Feb-25-21 09:30AM  
Feb-23-21 01:00PM  
Jan-26-21 10:15AM  
Jan-11-21 11:00AM  
Dec-17-20 09:45AM  
Dec-15-20 09:30AM  
Dec-10-20 12:10PM  
Dec-09-20 11:25AM  
Dec-04-20 09:30AM  
Nov-25-20 12:20PM  
Nov-16-20 05:33AM  
Nov-03-20 09:50AM  
Oct-22-20 09:30AM  
Oct-21-20 09:30AM  
Sep-30-20 09:25AM  
Sep-29-20 09:30AM  
Sep-25-20 10:00AM  
Sep-22-20 09:30AM  
Sep-09-20 09:00AM  
Sep-01-20 07:22PM  
Aug-31-20 05:00PM  
Aug-06-20 09:30AM  
Aug-05-20 09:00AM  
Jul-28-20 09:30AM  
Jul-22-20 09:45AM  
Jul-06-20 08:15AM  
Jun-25-20 09:30AM  
Jun-17-20 09:55AM  
Jun-15-20 09:30AM  
Jun-11-20 11:35AM  
Jun-10-20 10:06AM  
Jun-09-20 09:15AM  
Jun-08-20 09:30AM  
May-28-20 09:30AM  
May-04-20 10:15AM  
Apr-23-20 08:45AM  
Apr-16-20 10:17AM  
Apr-15-20 09:45AM  
Apr-09-20 09:30AM  
Mar-29-20 08:19AM  
Mar-26-20 09:15AM  
Mar-17-20 09:30AM  
Feb-19-20 09:37AM  
Feb-14-20 09:15AM  
Feb-06-20 12:30PM  
Jan-09-20 09:15AM  
Dec-30-19 05:36AM  
Dec-19-19 09:30AM  
Dec-16-19 09:00AM  
Dec-13-19 09:30AM  
Oct-29-19 08:30AM  
Oct-17-19 10:30AM  
Oct-07-19 09:26AM  
Oct-01-19 08:30AM  
Sep-27-19 11:52AM  
Sep-25-19 09:50AM  
Sep-11-19 09:15AM  
Sep-07-19 09:30AM  
Aug-06-19 04:30PM  
Jul-29-19 03:01PM  
Jun-19-19 09:00AM  
Jun-13-19 09:35AM  
Jun-06-19 09:00AM  
May-07-19 09:00AM  
Apr-30-19 09:00AM  
Apr-29-19 11:56AM  
Apr-22-19 09:00AM  
Apr-11-19 09:00AM  
Apr-04-19 09:00AM  
Apr-03-19 09:00AM  
Mar-26-19 09:00AM  
Mar-25-19 08:00AM  
Feb-28-19 03:02PM  
Feb-26-19 08:00AM  
Feb-21-19 01:35PM  
Feb-20-19 09:00AM  
Feb-15-19 08:30AM  
Feb-12-19 09:33AM  
Feb-07-19 09:15AM  
Feb-01-19 09:20AM  
Jan-24-19 08:30AM  
Jan-23-19 01:57PM  
Jan-17-19 09:00AM  
Jan-15-19 09:05AM  
Jan-10-19 08:00AM  
Dec-27-18 10:25AM  
Dec-26-18 04:18PM  
Dec-24-18 08:00AM  
Dec-20-18 06:50AM  
Adial Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of treatment for addictions. Its lead product is AD04, a selective serotonin-3 antagonist for the treatment of alcohol use disorder. The company was founded in 2010 and is based in Charlottesville, Virginia.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Johnson Bankole A.Chief Medical OfficerAug 20Sale1.21350,000423,5001,055Aug 24 04:59 PM
Newman James W. Jr.DirectorMar 27Buy1.3414,64419,66914,644Mar 30 09:23 AM
Newman James W. Jr.DirectorMar 27Buy1.425,0007,10015,000Mar 30 09:23 AM
Stilley William B. IIIChief Executive OfficerMar 26Buy1.4712,65218,598715,937Mar 27 06:03 AM
Stilley William B. IIIChief Executive OfficerMar 25Buy1.1312,34813,953703,285Mar 27 06:03 AM